Literature DB >> 8144941

Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols.

S M Anderton1, R van der Zee, A Noordzij, W van Eden.   

Abstract

Immunization of Lewis rats with heat-killed Mycobacterium tuberculosis (Mt) in mineral oil induces adjuvant arthritis (AA), associated with T cell responses to residues 180-188 of the mycobacterial 65-kDa heat shock protein (hsp65). Preimmunization with hsp65 protects rats against AA and other forms of arthritis. Several explanations for these protective effects have been proposed, including enhanced responsiveness to protective epitopes in hsp65, down-regulation of T cell responses to the 180-188 epitope, and activation of self-hsp60-reactive T cells. To assess the potential of these hypotheses, we analyzed hsp65 T cell epitopes recognized after immunization of Lewis rats with Mt or hsp65. Here we identify nine RT1.B1-restricted T cell epitopes in hsp65. Mt immunization induced T cell responses in which the 180-188 epitope was dominant, whereas hsp65 immunization resulted in a co-dominance of this and two further epitopes, 216-225 and 226-235. Two minor epitopes were recognized after hsp65 but not Mt immunization. These results indicate that hsp65 preimmunization does not down-regulate responses to the AA-associated epitope, but does enhance responses to several hsp65 epitopes that are minor or absent after the AA-inducing immunization protocol. Cross-reactive T cell recognition of hsp65 and rat hsp60 was limited to a single epitope (256-265), recognized after hsp65 immunization, but poorly recognized after Mt immunization. This study provides the necessary basis for elucidating the T cell events involved in the protective effects of hsp65 preimmunization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144941

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data.

Authors:  J A Borghans; L S Taams; M H Wauben; R J de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Qa-1 restriction of CD8+ suppressor T cells.

Authors:  Stefanie Sarantopoulos; Linrong Lu; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

Authors:  Francisco J Quintana; Doron Gerber; Sally C Kent; Irun R Cohen; Yechiel Shai
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

4.  Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

Authors:  G Kingsley; J Sieper
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 5.  Genetic vaccination against tuberculosis.

Authors:  D B Lowrie; C L Silva; R E Tascon
Journal:  Springer Semin Immunopathol       Date:  1997

Review 6.  Molecular chaperones and disease.

Authors:  B Henderson; S P Nair; A R Coates
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

7.  The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats.

Authors:  L Zhang; M Y Mia; C L Zheng; M A Hossain; F Yamasaki; O Tokunaga; O Kohashi
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

8.  Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance?

Authors:  B S Polla; S Baladi; K Fuller; G Rook
Journal:  Experientia       Date:  1995-08-16

Review 9.  The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal.

Authors:  Min-Nung Huang; Hua Yu; Kamal D Moudgil
Journal:  Semin Arthritis Rheum       Date:  2009-12-06       Impact factor: 5.532

10.  HSP60 as a target of anti-ergotypic regulatory T cells.

Authors:  Francisco J Quintana; Avishai Mimran; Pnina Carmi; Felix Mor; Irun R Cohen
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.